These results, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the notion of targeting ACKR3 as a singular strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked disorders. Scientists think that blocking this https://kedari961kdh6.wikicorrespondent.com/user